EUCTR2007-001471-11-DE进行中（未招募）不适用
Efficacy and safety of Aethoxysklerol 4% compared to 5% phenol in oil for the treatment of the first and second degree hemorrhoids - a pilot study
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Female and male patients with bleeding first and second degree hemorrhoids
- •2. Age 20-78 years
- •3. Weight > 50 kg
- •4. Patients who give written consent after oral and written information about the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Exclusion of pregnancy for female patients not possible
- •2. Breastfeeding
- •3. Patients with third or fourth degree hemorrhoids
- •4. Known allergy to Polidocanol (macrogol lauryl ether, Lauromacrogol 400) or other ingredients of Aethoxysklerol
- •5. Known allergy to Phenol, almond oil, almonds or nuts
- •6. Alcoholism
- •7. Patients who had a sclerotherapy due to hemorrhoidal disease within the last 6 months
研究者
相似试验
进行中（未招募）
不适用
Efficacy and safety of Aethoxysklerol compared to Sodium Tetradecyl Sulfate and Isotonic Saline (placebo) for the treatment of reticular veins and spider veins including subgroup to investigate the plasma concentrations of polidocanolEUCTR2006-004565-33-DEChemische Fabrik Kreussler & Co.GmbH
已完成
不适用
Evaluation of efficacy and safety of anti-sclerostin antibody romosozumab for osteoporosis in patients undergoing hemodialysisosteoporosis, end stage renal diseaseJPRN-UMIN000037579Tokai University School of Medicine25
尚未招募
不适用
This is a study to optimise the dosing regimen for Vancomycin so that patient response to the drug can be improved.CTRI/2023/02/049473Prof Nusrat Shafiq
进行中（未招募）
1 期
Evaluation of thesafety and efficacy of ambroxol in Gaucher disease caused by carrying the c.1448T>C mutation (p.Leu483Pro) and other rare variants of the GBA gene, based on clinical evaluation and results of genetic and metabolomic analysesGaucher diseaseEUCTR2021-006224-40-PLInstytut ,,Pomnik-Centrum Zdrowia Dziecka40
进行中（未招募）
不适用
The Comparison of the Efficacy and Safety of Arzoxifene versus Raloxifene in Postmenopausal Women with Osteoporosis. - NDPrevention and treatment of osteoporosis.MedDRA version: 6.1Level: PTClassification code 10031285EUCTR2006-001987-22-ITEli Lilly and Company Limited300